Lista de obras -

A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy.

artículo científico publicado en 2017

Artefactual punctate MLH1 staining can lead to erroneous reporting of isolated PMS2 loss

artículo científico publicado en 2018

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

artículo científico publicado en 2017

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

artículo científico publicado en 2017

High-grade serous carcinoma of tubo-ovarian origin: recent developments.

artículo científico

Interleukin-6 as a therapeutic target in human ovarian cancer

artículo científico publicado en 2011

Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871-879

artículo científico publicado en 2020

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

scientific article published on 06 September 2019

Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances

artículo científico publicado en 2020

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.

artículo científico publicado en 2016

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

artículo científico publicado en 2015

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

artículo científico publicado en 2019

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule

artículo científico publicado en 2012

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

artículo científico publicado en 2015

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

artículo científico publicado en 2009

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

artículo científico publicado en 2010

The changing landscape of gynaecological pathology: WHO 2020 and beyond

artículo científico publicado en 2020

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

artículo científico publicado en 2017

Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma

scientific article published on 26 July 2019

Vulval squamous cell carcinoma and its precursors

artículo científico publicado en 2020

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2023

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

artículo científico publicado en 2020

Lista de obras de

A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy.

Artefactual punctate MLH1 staining can lead to erroneous reporting of isolated PMS2 loss

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

High-grade serous carcinoma of tubo-ovarian origin: recent developments.

Interleukin-6 as a therapeutic target in human ovarian cancer

Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871-879

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

The changing landscape of gynaecological pathology: WHO 2020 and beyond

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma

Vulval squamous cell carcinoma and its precursors

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies